What is Aliath Bioventures?
Aliath Bioventures aims to impact patients’ lives and healthcare systems by working hand in hand with entrepreneurs to create new healthcare solutions developed by sustainable companies. As a life sciences venture capital investor and an investment advisor to AltamarCAM, Aliath specializes in the life sciences and healthcare markets. Their team advises AltamarCAM on investment strategy and execution, sourcing, structuring, and developing investments that truly matter.
Main Benefits and Key Highlights
Aliath Bioventures stands out by combining deep industry knowledge with a clear mission. Here are some key facts that showcase their impact:
- Team of industry veterans and investment experts with extensive healthcare ecosystem knowledge.
- Investment approach aligned with impact goals, investing alongside fund investors.
- Focus on companies built on disruptive trends addressing unmet medical needs.
- Targets therapeutics and health technology companies from seed to late stage.
- Applies a unique 3-i framework: innovation, intention, and impact.
- Designs protocols to help portfolio companies improve sustainability and competitiveness.
Inspired by Mission, Driven by Experience
Aliath’s team is formed of seasoned professionals with complementary backgrounds and a proven track record. They’re not just investors; they’re partners who align their carry with the impact goals of the funds. This alignment ensures that everyone is motivated to turn healthcare challenges into real business opportunities. It’s about more than just capital—it’s about making a difference.
Turning Healthcare Challenges into Opportunities
The healthcare landscape is full of unmet needs and sustainability challenges. Aliath Bioventures seeks out companies that ride disruptive trends, offering innovative solutions that can transform patient care and healthcare systems. By focusing on these opportunities, they help build companies that are not only competitive but also sustainable in the long run.
Innovation, Intention, and Impact: The 3-i Framework
At the core of Aliath’s approach is the 3-i framework—innovation, intention, and impact. This means targeting companies that bring cutting-edge therapeutics and health technologies to the table, while applying impact principles and standards throughout the investment process. The goal? To tackle some of the most pressing healthcare challenges of our time with solutions that truly matter.
Project Impact and Sustainable Development Goals (SDGs)
- Good Health and Well-being (SDG 3)
- Industry, Innovation, and Infrastructure (SDG 9)
- Reduced Inequalities (SDG 10)
- Responsible Consumption and Production (SDG 12)
- Partnerships for the Goals (SDG 17)
Latest News & Insights
Aliath Bioventures stays at the forefront of innovation with exciting developments from its portfolio companies. For instance, Inbiomotion is commercializing its proprietary MAF Test® to identify high-risk early-stage breast cancer, showing significant cost savings through guided therapy. Meanwhile, INBRAIN Neuroelectronics has teamed up with Mayo Clinic to push forward graphene-based brain-computer interfaces. Peptomyc S.L. recently announced a leadership transition to fuel its next growth phase, and Deepull secured an oversubscribed €50 million Series C to advance its Ullcore diagnostic system for rapid pathogen detection. Accure Therapeutics received $1.6M in grants to bring a first-in-class Parkinson’s drug to clinical trials. Plus, Peptomyc got approval for a Research IND trial in collaboration with OHSU Knight Cancer Institute, targeting pancreatic cancer patients. These stories highlight the dynamic and impactful nature of Aliath’s investments.
